第75回日本循環器学会総会・学術集会DVD-ROM

第75回夏期学術集会ＤＶＤに多数のお申込みをいただき有難うございました。
当ＤＶＤの販売は2012年3月31日でもって全て終了いたしました。

ＤＶＤへの収録は、第75回日本循環器学会総会・学術集会に於いて収録予定の下記収録内容の内、座長、演者の先生方のご同意が得られた内容が対象になります。

美甘レクチャー

座長：

Shigetake Sasayama (Faculty of Life and Medical Sciences, Doushisha University, Kyoto)

ML. Cardiopoiesis: Genetic Circuits for Cardiac Muscle Creation by Embryonic Cells

Michael D. Schneider (British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London, UK)

真下記念講演

座長：

矢﨑義雄 (独立行政法人国立病院機構)

MML. Regulation Mechanisms of Intracellular Calcium Dynamics: Its Physiology and Pathology

御子柴克彦 (理化学研究所　脳科学総合研究センター　発生神経生物研究チーム)

会長講演

座長：

松﨑益德 (山口大学器官病態内科学)

CCL. Changes in Cardiology as Viewed from the Aspect of Arrhythmia Research: From Physiology to Molecular Cardiology to Prospects for the Future

小川聡 (慶應義塾大学／国際医療福祉大学三田病院)

会長特別企画

SS1. ヒト iPS 細胞由来心筋樹立による家族性突然死症候群の病態解明と治療法の確立

座長：

堀江稔 (滋賀医科大学呼吸循環器内科)
福田恵一 (慶應義塾大学循環器内科)

SS1-1. Future Prospect of Arrhythmia Analysis Using Human iPS Cellderived Cardiomyocytes Obtained from Hereditary QT Prolongation Syndrome

福田恵一 (慶應義塾大学循環器内科)

SS1-2. Generation of Induced Pluripotent Stem Cells from Human Peripheral Blood: Less Invasive and Clinically Applicable Technique

湯浅慎介 (慶應義塾大学　循環器内科)

SS1-3. Potential Role of iPS Cell-derived Cardiomyocyte for Tailor-made Therapy and Unveiling Pathogenesis in Patient with Congenital Long QT Syndrome

清水渉 (国立循環器病研究センター　心臓血管内科)

SS1-4. Molecular Analysis of Long QT Syndromes Type 1 Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocyte

神谷香一郎 (名古屋大学環境医学研究所　心・血管分野)

SS1-5. Electrophysiological Characterization of Cardiomyocyte-like Cells Differentiated from Human iPS Cells

古川哲史 (東京医科歯科大学　難治疾患研究所　生体情報薬理学)

SS1-6. Functional Basis of Type 3 Long QT Syndrome

蒔田直昌 (長崎大学　内臓機能生理学)

SS3. New Trends in Antithrombotic Therapy in Patients with Atrial Fibrillation

座長：

井上博 (富山大学第二内科)
堀正二 (大阪府立成人病センター)

SS3-1. An Antithrombin Inhibitor, Dabigatran as a New Anticoagulant for Patients with Atrial Fibrillation

堀正二 (大阪府立成人病センター)

SS3-2. Stroke Prevention with Novel Anticoagulants in Afib Patients with Prior Stroke or TIA

内山真一郎 (東京女子医科大学　神経内科)

SS3-3. Current Japanese Guideline and the New Era of the Antithrombotic Therapy for Atrial Fibrillation

是恒之宏 (国立病院機構大阪医療センター　臨床研究センター)

SS3-4. Present Status of Anticoagulation Treatment in Japanese Patients with Atrial Fibrillation - A Report from the J-RHYTHM Registry

新博次 (日本医科大学多摩永山病院　内科・循環器内科)

SS3-5. A Novel Quantification Tool of Assessing the Risk of Bleeding in Patients with Atrial Fibrillation

渡邉英一 (藤田保健衛生大学　循環器内科)

SS3-6. Future Perspective of Warfarin and Newer Generation of Oral Anticoagulants

Kenneth W. Mahaffey (Duke University Health System, USA)

プレナリーセッション

PL1. Recent Advances in the Diagnosis of Ischemic Heart Disease with Imaging

座長：

Masakazu Yamaishi (Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa)
Takashi Akasaka (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)

PL1-1. Plaque Characteristics on Computed Tomography Coronary Angiography Which will Cause Acute Coronary Syndrome

Shinichiro Fujimoto (Department of Cardiology, Takase Clinic, Takasaki)

PL1-2. Cardiac PET: From Myocardial Perfusion Imaging to Quantification of Myocardial Blood Flow

Keiichiro Yoshinaga (Department of Photobiology, Hokkaido University Graduate School of Medicine, Sapporo)

PL1-3. What Should We Clarify for What by Coronary Imaging in Daily Clinical Practice? - Insight from Angioscopic Examinations -

Yasunori Ueda (Cardiovascular Division, Osaka Police Hospital, Osaka)

PL1-4. Mechanism of Coronary Plaque Rupture Assessed by Integrated Three-dimensional Intravascular Imaging

Takafumi Hiro (Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo)

PL1-5. Impact of Strut Thickness on Atherosclerotic Change in Neointima ≧5 Years after Bare-metal Stent Implantation: Optical Coherence Tomography Examination

Hironori Kitabata (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)

PL1-6. Tissue Morphological Assessment by Optical Coherence Tomography in In-stent Restenosis Lesions after SES, PES and BMS Implantation

Shingo Hosogi (Kochi Health Sciences Center/Kurashiki Central Hospital, Kochi)

PL2. Recent Advances in the Management of Dyslipidemias: From Bench to Bedside

座長：

Kazuyuki Shimada (Cardiology, Internal Medicine, Jichi Medical University Hospital, Tochigi)
Keijiro Saku (Department of Cardiology, Fukuoka University School of Medicine, Fukuoka)

PL2-1. Cell Cholesterol Removal Reactions as Targets for Antiatherogenic Therapy

Shinji Yokoyama (Biochemistry, Nagoya City University Graduate School of Medical Sciences, Nagoya)

PL2-2. FAMP, A Powerful Producer of Pre-β HDL, Enhances Reverse Cholesterol Transport and Improves Survival Rate in A Myocardial Infarction Model

Shinichiro Miura (Department of Cardiology, Fukuoka University School of Medicine, Fukuoka)

PL2-3. MicroRNA-33 Encoded by an Intron of Srebp2 Cooperates to Control HDL in Vivo

Koh Ono (Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto)

PL2-4. Development of Nucleic Acid Drug for Dyslipidemia Using 2',4'- BNA/LNA

Mariko Shiba (National Cerebral and Cardiovascular Center Research Institute, Suita)

PL2-5. Treatment of Postprandial Hypertiglyceridemia for Improvement of Atherogenic Lipoprotein Profile -Two Different Therapies by Fenofibrate and Ezetimibe-

Daisaku Masuda (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka)

PL5. 慢性腎臓病 Up-to-date

座長：

島本和明 (札幌医科大学)
檜垣實男 (愛媛大学病態情報内科学)

Possible Role of Over-activation of Mineralcorticoid Receptor (MR) through Post-translational Modification in Chronic Kidney Diseases (CKD)

伊藤裕 (慶應義塾大学　腎臓内分泌代謝内科)

eNOS Dysfunction as a Promising Therapeutic Target for Saltsensitive CKD as well as Cardio-renal Connection

光山勝慶 (熊本大学　生体機能薬理学)

PL5-1. Elevated Levels of Serum Cystatin C Predict Early Stage of Coronary Atherosclerotic Plaque Detected by Multidetector Computed Tomography

今井敦子 (尼崎中央病院　心臓血管センター)

PL5-2. Cardiovascular Disease Continuum in Chronic Kidney Disease

後藤淳郎 (日本赤十字社医療センター　内科)

PL5-3. The Pathogenesis of Cardio-Renal Syndrome in Acute Coronary Syndrome

鈴木誠 (愛媛大学　地域救急医療学講座)

PL5-4. Chronic Kidney Disease as an Independent Risk Factor for NewOnset Atrial Fibrillation in Hypertensive Patients

堀尾武史 (川崎医科大学総合内科学３)

PL5-5. Endothelial Dysfunction is a Significant Determinant Factor of Contrast-Induced Renal Dysfunction in Patients with Early Stage of Chronic Kidney Disease

角田等 (熊本大学　循環器病態学)

PL5-6. Impact of CKD on Long-term Prognosis of Coronary Artery Disease Associated with Hypertension: Insights from Effects of Calcium Channel Blockers

新田裕 (富山赤十字病院　循環器内科)

シンポジウム

SY1. 急性冠症候群の治療 ─Beyond the Reperfusion─

座長：

野原隆司 (北野病院心臓センター)
平山篤志 (日本大学循環器内科)

SY1-1. Erythropoietin for the Treatment of Acute Myocardial InfarctionDouble Blind, Placebo-controlled, Randomized Multicenter Clinical Trial (EPO/AMI-II)

南野哲男 (大阪大学　循環器内科学)

SY1-2. Impact of Proton Pump Inhibitor (PPI) and CYP2C19 Polymorphism on Clinical Outcomes in Acute Coronary Syndrome (ACS) Patient

掃本誠治 (熊本大学　循環器病態学)

SY1-3. Platelet Reactivity Assessed by a Point-of-Care Assay (VerifyNowP2Y12) in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

野口将彦 (小倉記念病院　循環器科)

SY1-4. New Agendas in the Management of ST Segment Elevation Myocardial Infarction: Lessons from the Osaka Acute Coronary Insufficiency Study

坂田泰彦 (大阪大学　循環器内科学)

SY1-5. Early Stabilization of Residual Vulnerable Coronary Plaques after Revascularization in ACS Patients

田口功 (獨協医科大学　心臓・血管内科)

SY1-6. Effects of Strong Statin on the Plaque Modification as Evaluated by Coronary Angioscopy and Intravascular Ultrasound in Japanese Subjects

髙山忠輝 (日本大学　循環器内科)

SY2. 冠攣縮の最新の知見

座長：

小川久雄 (熊本大学循環器病態学)
下川宏明 (東北大学循環器内科学)

SY2-1. Conformational Change of Vascular Structure in Vasospastic Angina: An Optical Coherence Tomography Study

田中篤 (和歌山県立医科大学　循環器内科学)

SY2-2. Characteristics of Patients with Urgent Vasospastic Angina

西垣和彦 (岐阜大学　第二内科)

SY2-3. Clinical Characteristics and Outcomes of Vasospastic Angina Patients Survived from Out-of-Hospital Cardiac-Arrest -A Report from the Japanese Coronary Spasm Association-

安田聡 (東北大学　循環器内科学)

SY2-4. Prognostic Value of Exercise Stress Myocardial Perfusion Imaging in Patients with Vasospastic Angina

中込明裕 (日本医科大学多摩永山病院　内科・循環器内科)

SY2-5. Changes in Diagnosis Frequency of Coronary Vasospastic Angina (VSA) and Relation Between Vasomotor Activity and Treatment of Intractable Coronary Spasm

海北幸一 (熊本大学　循環器病態学)

SY2-6. New Strategy of Medical Therapy to Left Ventricular Dysfunction without Significant Coronary Stenosis

伊波巧 (杏林大学　第二内科)

SY4. New Strategy of Catheter Ablation for Chronic Atrial Fibrillation

座長：

Kazutaka Aonuma (Cardiovascular Division, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukub)
Hideo Mitamura (Department of Cardiology, Saiseikai Central Hospital, Tokyo)

SY4-1. Left Atrial Linear Ablation in Patients with Persistent Atrial Fibrillation:Impact of Linear Ablation on Continuous Fractionated Electrogram

Seiichiro Matsuo (Department of Cardiology, The Jikei University School of Medicine, Tokyo)

SY4-2. Substrate Ablation of Atrial Fibrillation Solely Guided by Complex Fractionated Atrial Electrogram Mapping ~The Termination Rate and the Outcome

Naoya Oketani (Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima)

SY4-3. Visualization of Activation Patterns at Sites with Complex Fractionated Atrial Electrograms Can Facilitate Ablation of Persistent Atrial Fibrillation?

Koji Azegami (Heart Center, Yokohama Bay City Red Cross Hosopital, Yokohama)

SY4-4. Hybrid Therapy with Extensive Antiarrhythmic Drugs and the Following Catheter Ablation as a Novel Approach for Long-lasting Persistent Atrial Fibrillation

Hiroshi Tada (Cardiovascular Division, Institute of Clinical Medicine Graduate School of Comprehensive Human Sciences, University of Tsukuba)

SY4-5. Efficacy of Combining Box Isolation Plus Ablation of Complex Fractionated Atrial Electrograms Localized with Antiarrhythmic Drugs for Chronic Atrial Fibrillation

Koichiro Kumagai (Heart Rhythm Center, Fukuoka Sanno Hospital, Fukuoka)

SY4-6. Noninducibility of Atrial Fibrillation and Ectopy by High-dose Isoproterenol Is Useful End Point of Persistent Atrial Fibrillation Ablation

Taishi Kuwahara (Department of Cardiology, Yokosuka Kyousai Hospital, Kanagawa)

SY8. Therapeutic Approach for Acutely Decompensated Heart Failure

座長：

Hiroshi Itoh (Department of Cardiovascular and Respiratory Medicine, Akita University Graduate School of Medicine, Akita)
Tsutomu Yoshikawa (Department of Cardiology, Sakakibara Heart Institute, Tokyo)

SY8-1. Recent Advances in the Management of Acutely Decompensated Failure; Insights from Tokyo CCU Network Database

Shun Kohsaka (Tokyo CCU Network Scientific Committee, Tokyo)

SY8-2. Noninvasive Simultaneous Measurement of Systemic Vascular Resistance and Cardiac Power Would Provide Optimal Drug Selection in Acute Decompensated Heart Failure

Kazuhiko Hashimura (Division of Cardiology, Yao Municipal Hospital, Yao)

SY8-3. How to Find High Risk Patients Prone to Develop Postoperative Right Ventricular Failure before Left Ventricular Assist Device Implantation?

Koichiro Kinugawa (Department of Cardiovascular Medicine, University of Tokyo, Tokyo)

SY8-4. Current Status and Perspectives Regarding Managements of Acute Heart Failure with Kidney Disease

Naoki Sato (Internal Medicine, Cardiology, and Intensive Care Unit, Nippon Medical School Musashi Kosugi Hospital)

SY8-5. Reduced Glomerular Filtration Rate and Albuminuria are Significant Mortality Risks in Patients with Cardiovascular Diseases

Nobuyuki Shiba (Department of Evidence-Based Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai)

SY11. RAA 系のニューパラダイム

座長：

小室一成 (大阪大学循環器内科学)
吉村道博 (東京慈恵会医科大学循環器内科)

SY11-1. The (Pro)Renin Receptor is Essential for Vacuolar H+-ATPase Assembly in Murine Cardiomyocytes

佐野元昭 (慶應義塾大学　循環器内科)

SY11-2. Angiotensin II Type 1 Receptor-Associated Protein, ATRAP, Functions as a Selective Inhibitory Molecule of Receptor Signaling at Local Tissue Sites

田村功一 (横浜市立大学　循環器内科学・腎臓内科学)

SY11-3. Bone Marrow Angiotensin AT1 Receptor Regulates Differentiation of Monocyte Lineage Progenitors from Hematopoietic Stem Cells

山田浩之 (京都府立医科大学　循環器内科学)

SY11-4. Agonist-Dependent and -Independent Activation of Angiotensin II Receptor in the Pathogenesis of Cardiovascular Remodeling

赤澤宏 (大阪大学　循環器内科学)

SY11-5. Novel, Nongenomic, and Protective Cascade of Aldosterone via Na+/H+ Exchanger 1, PI3-kinase, and Akt Signaling in Cardiomyocytes

名越智古 (東京慈恵会医科大学　循環器内科)

SY11-6. Clinical Parameters including the RAA Systems During Treatment with Selective Aldosterone Blocker, Eplerenone in Patients with Bilateral Adrenal Hyperaldosteronemia (IHA)

西川哲男 (横浜労災病院　内科)

SY11-7. Clinical Impact of Renin Angiotensin Aldosterone System Gene Polymorphisms on Subsequent Cardiac Events after Acute Myocardial Infarction

松本専 (大阪大学　循環器内科学)

SY13. Current Advances in Echocardiography

座長：

Kiyoshi Yoshida (Department of Cardiology, Kawasaki Medical School, Okayama)
Yutaka Otsuji (Second Department of Internal Medicine, University of Occupational and Environmental Health, Fukuoka)

SY13-1. Recent Advances in the Management of Acutely Decompensated Failure; Insights from Tokyo CCU Network Database

Masaaki Takeuchi (Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu)

SY13-2. Noninvasive Simultaneous Measurement of Systemic Vascular Resistance and Cardiac Power Would Provide Optimal Drug Selection in Acute Decompensated Heart Failure

Toshihiko Asanuma (Division of Functional Diagnostics, Department of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka)

SY13-3. How to Find High Risk Patients Prone to Develop Postoperative Right Ventricular Failure before Left Ventricular Assist Device Implantation?

Yoshihiro Seo (Cardiovascular Division, Graduate School of Comprehensive Human Science, University of Tsukuba, Tsukuba)

SY13-4. Current Status and Perspectives Regarding Managements of Acute Heart Failure with Kidney Disease

Mika Mori (Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa)

SY13-5. Reduced Glomerular Filtration Rate and Albuminuria are Significant Mortality Risks in Patients with Cardiovascular Diseases

Shiro Iwanaga (Tokyo Medical University Hachioji Medical Center, Tokyo)

SY14. Cardiac CT and MRI: State of the Art

座長：

Kyoichi Mizuno (Division of Cardiology, Department of Internal Medicine, Nippon Medical School, Tokyo)
Sachio Kuribayashi (Department of Radiology, Keio University School of Medicine, Tokyo)

SY14-1. A New Method for Quantifying Myocardial Perfusion by 320-Slice Computed Tomography Can Improve Diagnostic Accuracy for Detecting Coronary Artery Stenosis

Yoshihiro Takeda (Second Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu)

SY14-2. Cardiac Computed Tomography Assessment of Pericardial Fat Associated with Coronary Atherosclerosis and Left Ventricular Diastolic Dysfunction

Masaaki Konishi (Division of Functional Diagnostics, Department of Health Sciences, Osaka University Graduate School of Medicine, Suita, Osaka)

SY14-3. Diagnosis and Treatment of Vulnerable Plaque Based on Computed Tomography Angiography

Sadako Motoyama (Cardiovascular Division, Graduate School of Comprehensive Human Science, University of Tsukuba, Tsukuba)

SY14-4. Hyperintense Coronary Plaque Detected by Noncontrast T1- Weighted Magnetic Resonance Imaging Predicts Coronary Events in Patients with Coronary Artery Disease

Atsushi Tanaka (Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa)

SY14-5. Non Invasive Coronary Plaque Imaging with Cardiac Magnetic Resonance

Yasuyo Taniguchi (Department of Cardiology, Himeji Cardiovascular Center, Himeji)

SY15. New Biomarkers for Prediction and Prevention of Cardiovascular Diseases

座長：

>Ryozo Nagai (Graduate School of Medicine and Faculty of Medicine, Department of Cardiovascular Medicine, The University of Tokyo, Tokyo)
Hiroyasu Iso (Public Health, Department of Social and Environmental Medicine, Osaka University, Graduate School of Medicine, Osaka)

SY15-1. Risk Stratification of Cardiovascular Diseases Using a Circulating Marker of Endothelial Dysfunction: Endothelium-DerivedMicroparticles

Toshimitsu Nozaki (Amakusa Medical Center, Amakusa)

SY15-2. Cyclophilin A is a Novel Biomarker for Aortic Aneurysms and Atherosclerotic Plaque Instability

Kimio Satoh (Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai)

SY15-3. Circulating CD14+CD16+CX3CR1+ Monocytes Levels as a Novel Biomarker of Coronary Vulnerable Plaque

Toshio Imanishi (Department of Cardiovasuclar Medicine, Wakayama Medical University, Wakayama)

SY15-4. Detection of Specific Periodontal Pathogens in Blood or Oral Samples is a Useful Biomarker for the Prediction of Cardiovascular Diseases

Jun-ichi Suzuki (Department of Advanced Clinical Science and Therapeutics, University of Tokyo, Tokyo)

SY15-5. Long-term Prognostic Value of Plasma Adrenomedullin Levels in Patients with Chronic Stable Cardiovascular Disease

Toshio Nishikimi (Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto)

SY15-6. Impact of Triglyceride-Rich High-Density Lipoprotein Composition as a New Marker for Development of Angiographic Coronary Artery Disease

Atsushi Nohara (Department of Lipidology, Kanazawa University Graduate School of Medical Science, Kanazawa)

SY21. 肺高血圧症の最新治療

座長：

伊藤正明 (三重大学　循環器･腎臓内科学)
佐藤徹 (杏林大学循環器内科)

SY21-1. Risk Stratification of Cardiovascular Diseases Using a Circulating Marker of Endothelial Dysfunction: Endothelium-DerivedMicroparticles

溝口博喜 (岡山医療センター　循環器科)

SY21-2. Cyclophilin A is a Novel Biomarker for Aortic Aneurysms and Atherosclerotic Plaque Instability

渡邉裕司 (浜松医科大学　臨床薬理学)

SY21-3. Circulating CD14+CD16+CX3CR1+ Monocytes Levels as a Novel Biomarker of Coronary Vulnerable Plaque

辻明宏 (三重大学　循環器内科学)

SY21-4. Detection of Specific Periodontal Pathogens in Blood or Oral Samples is a Useful Biomarker for the Prediction of Cardiovascular Diseases

片岡雅晴 (杏林大学　第二内科)

SY21-5. Long-term Prognostic Value of Plasma Adrenomedullin Levels in Patients with Chronic Stable Cardiovascular Disease

杉村宏一郎 (東北大学　循環器病態学分野)

SY21-6. Impact of Triglyceride-Rich High-Density Lipoprotein Composition as a New Marker for Development of Angiographic Coronary Artery Disease

瀧原圭子 (大阪大学　保健センター　循環器内科学)

SY23. 弁形成術の最近の進歩

座長：

坂田隆造 (京都大学医学部附属病院心臓血管外科)
中谷敏 (大阪大学機能診断科学)

SY23-1. Mitral Valve Plasty for Mitral Regurgitation in Different Etiology

磯村正 (葉山ハートセンター　心臓血管外科)

SY23-2. Assessment of Mitral Valve Configuration before and after Surgery Using Novel Imaging Modalities

西宏之 (大阪大学　心臓血管外科)

SY23-3. Long-term Outcome after Aortic Valve Repair for Aortic Insufficiency

向井田昌之 (岩手医科大学　心臓血管外科)

SY23-4. Stabilization of the Aortic Root and Aortic Regurgitation after Valve-sparing Root Replacement with Cusp Repair

岡隆紀 (神戸大学　心臓血管外科学)

SY23-5. Long-term Results of Tricuspid Valve Annuloplasty with and without Ring. Is a Ring Annuloplasty Superior to a De Vega Procedure?

腰地孝昭 (福井大学　外科学（２）)

SY23-6. Early and Midterm Results of Tricuspid Valve Surgery in a Modern Era

小林豊 (東京女子医科大学　心臓血管外科)

SY24. 心血管疾患のリハビリテーション

座長：

和泉徹 (北里大学循環器内科学)
後藤葉一 (国立循環器病研究センター心臓血管内科)

SY24-1. The Impact of Phase1 positive Cardiac Rehabilitation after Coronary Artery Bypass Grafting

氏家敏巳 (大阪府済生会野江病院　心臓血管外科)

SY24-2. Cardiac Rehabilitation in Phase II Rehabilitation Hospital

川内基裕 (イムス板橋リハビリテーション病院　心大血管リハビリテーション科)

SY24-3. Effect of Cardiac Rehabilitation on Exercise Capacity and Left Ventricular Diastolic Function after Aortic Valve Replacement for Aortic Stenosis

長山雅俊 (榊原記念病院　循環器内科)

SY24-4. Cardiac Rehabilitation after Device Implantation

白石裕一 (京都府立医科大学　循環器内科学)

SY24-5. Cardiac Rehabilitation Might Improve the Prognosis of Patients with LVAS

簗瀬正伸 (国立循環器病研究センター　移植部)

フォーカスセッション

F1. 日本心臓財団 40周年記念事業

座長：

伊藤裕 (慶應義塾大学腎臓内分泌代謝内科)
野出孝一 (佐賀大学　循環器内科)

理事長挨拶

矢崎義雄 (独立行政法人国立病院機構)

F1-1. Regression of Hypertension-Significance of "Angiotensin Block Memory"

伊藤裕 (慶應義塾大学腎臓内分泌代謝内科)

F1-2. AGEs and Metabolic Memory

山岸昌一 (久留米大学　糖尿病性血管合併症病態・治療学講座)

F1-3. Metabolic Syndrome and Epigenetics

酒井寿郎 (東京大学　先端科学技術研究センター代謝医学分野)

F1-4. Molecular Mechanism of Circadian Clock Gene Regulation

野出孝一 (佐賀大学　循環器内科)

F1-5. Role of Clock Genes in the Development of Cardiovascular Diseases

前村浩二 (長崎大学　循環病態制御内科学)

F1-6. Clocks in the NAD World: Roles of SIRT1 and NAMPT-mediated NAD Biosynthesis in a Systemic Control of Metabolism and Aging

今井眞一郎 (Department of Developmental Biology, Washington University School of Medicine, St. Louis, USA)

F2-1. 心不全における非薬物治療の進歩：Part I CRT の適応と治療効果判定

座長：

松田直樹 (東京女子医科大学循環器内科)
安藤献児 (小倉記念病院循環器科)

F2-1-1. Echocardiographic Assessment of CRT Indication and Its Problem

鶴田ひかる (慶應義塾大学病院　循環器内科)

F2-1-2. Usefulness of Speckle Tracking Echocardiography in Patient Selection for Cardiac Resynchronization Therapy

古堅あずさ (東京女子医科大学　循環器内科)

F2-1-3. Predictive Value for CRT Response of QRS Duration and QRS Morphology

石川利之 (横浜市立大学附属病院　循環器内科)

F2-1-4. Effect of the Left Ventricular Lead Location on the Response to Cardiac Resynchronization Therapy in Patients with Advanced Heart Failure

夛田浩 (筑波大学　循環器内科)

F2-1-5. Cardiac Resynchronization Therapy Utilization Beyond Current Guideline

有田武史 (小倉記念病院　循環器科)

F2-2. 心不全における非薬物治療の進歩：Part II 重症心不全治療の現状と未来

座長：

北風政史 (国立循環器病研究センター心臓血管内科部門)
吉川勉 (榊原記念病院循環器内科)

F2-2-1. Treatment of Sleep Disordered Breathing in Advanced Heart Failure

百村伸一 (自治医科大学附属さいたま医療センター　循環器科)

F2-2-2. Immunoadsorption Therapy for Patients with Refractory Heart Failure due to Dilated Cardiomyopathy

吉川勉 (榊原記念病院　循環器内科)

F2-2-3. Mitral Valve Repair for Severe Functional Mitral Regurgitation in Dilated Cardiomyopathy

小野稔 (東京大学　心臓外科)

F2-2-4. Present Status and Future Trend of Ventricular Assist Systems and Heart Transplantation

中谷武嗣 (国立循環器病研究センター　移植部)

緊急シンポジウム

緊SY. 東日本大震災から学ぶ ―災害医療の在り方―

座長：

下川宏明 (東北大学循環器内科学)

緊SY-1. 行政の立場から

佐々木淳 (宮城県保健福祉部)

緊SY-2. 医師会の立場から

登米祐也 (宮城県医師会)

緊SY-3. 被災地の医師の立場から

祐川博康 (石巻赤十字病院　循環器科)

緊SY-4. 後方支援の大学病院の立場から

安田聡 (東北大学　循環器内科学)

緊SY-5. 日本循環器学会の立場から

野々木宏 (国立循環器病研究センター　心臓内科)

Windows：
Intel Pentium 4 2.33GHz 同等以上のプロセッサ
256MB RAM（512MB 以上推奨）
1024×768／16 ビットのカラービデオディスプレイアダプタ
プラットホーム：Windows 2000、Windows XP、Windows Vista、Windows 7
ブラウザ：Microsoft Internet Explorer 6 以降、Firefox 2.x 以降、AOL 9、Opera9.5以上、Safari 3.x

Macintosh：
PowerPC G4 1.25GHz以上のプロセッサ
Intel Core Duo 1.33GHz以上のプロセッサ
256MB RAM（512MB 以上推奨）
1024×768／16 ビットのカラービデオディスプレイアダプタ
プラットホーム：Mac OS X v10.4.x、10.5
ブラウザ：Firefox 2.x 以降、AOL for Mac OS X、Opera 9.5、Safari 3.x